A Kagramanova

716 citations

46 papers · 108 · h-index 6

Impact in

Genetics
- Inflammatory Bowel Disease
- Mesenchymal stem cell research
Epidemiology
- Microscopic Colitis
- Autoimmune and Inflammatory Disorders

Papers in

Genetics 36
- Inflammatory Bowel Disease 35
Epidemiology 28
- Microscopic Colitis 22
- Autoimmune and Inflammatory Disorders 6

Co-authors: O. V. Knyazev (42 shared papers)А И Парфенов (33 shared papers)А. V. Veselov (2 shared papers)Orlova Nv (2 shared papers)И. Г. Бакулин (1 shared paper)Л. С. Круглова (1 shared paper)E. А. Belousova (1 shared paper)П. Л. Щербаков (3 shared papers)
Journals: Journal of Crohn s and Colitis (7 papers)The American Journal of Gastroenterology (3 papers)Terapevticheskii arkhiv (14 papers)Inflammatory Bowel Diseases (1 paper)Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences (1 paper)
Partner nations: Russia South Korea United States

In The Last Decade

A Kagramanova

41 papers receiving 100 citations

Peers

Countries citing papers authored by A Kagramanova

Since Specialization

Citations

This map shows the geographic impact of A Kagramanova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Kagramanova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Kagramanova more than expected).

Fields of papers citing papers by A Kagramanova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Kagramanova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Kagramanova. The network helps show where A Kagramanova may publish in the future.

Co-authors

The 15 scholars most cited alongside A Kagramanova, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A Kagramanova Line = papers co-authored together A Kagramanova links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Epidemiology of inflammatory bowel disease. State of the problem (review) Russian Journal of Evidence-Based Gastroenterology ·O. V. Knyazev, Т. В. Шкурко, A Kagramanova, А. V. Veselov, Е. Л. Никонов	2020	18
2	Stem Cell Therapy for Perianal Crohn’s Disease Terapevticheskii arkhiv ·O. V. Knyazev, Н А Фадеева, A Kagramanova, N. I Belyakov, Orlova Nv, A Lishchinskaya, Anatoly Konoplyannikov, А И Парфенов	2018	11
3	EXPERIENCE OF TOFACITINIB USING IN THERAPY OF ULCERATIVE COLITIS IN REAL CLINICAL PRACTICE Koloproktologia ·E. А. Belousova, Вю I. Abdulganieva, О. П. Алексеева, И. Г. Бакулин, O. V. Vasilyeva, А. V. Veselov, A Kagramanova, V. N. Kashnikov, O. V. Knyazev, Marina Koroleva, Н. В. Никитина, Н. Н. Николаева, А. В. Ткачев, T. Yu. Chashkova, М. В. Шапина	2019	9
4	O.V. Knyazev, A.V. Kagramanova, I.A. Korneeva, K.K. Noskova, S.V. Belousov, A.I. Parfenov SHILAP Revista de lepidopterología ·O. V. Knyazev, A Kagramanova, I A Korneeva, К. К. Носкова, С. В. Белоусов, А И Парфенов	2019	6
5	Mesenchymal stromal cells of bone marrow and azathioprine in Crohn's disease therapy Terapevticheskii arkhiv ·O. V. Knyazev, A Kagramanova, Н А Фадеева, A Lishchinskaya, О Н Болдырева, К. К. Носкова, Р Б Гудкова, A. G. Konoplyannikov, А И Парфенов	2018	5
6	Psoriasis and inflammatory bowel diseases: pathogenetic pathways and the choice of biologic therapy (a literature review) SHILAP Revista de lepidopterología ·Л. С. Круглова, А. N. Lvov, A Kagramanova, O. V. Knyazev	2019	5
7	Long-term infliximab therapy for ulcerative colitis in real clinical practice Terapevticheskii arkhiv ·O. V. Knyazev, А И Парфенов, A Kagramanova, И Н Ручкина, П. Л. Щербаков, Nikolay K. Shakhpazyan, К. К. Носкова, T I Ivkina, С Г Хомерики	2016	4
8	P413 Relative frequency of relapses in patients with ulcerative colitis and Crohn's disease treated with mesenchymal stromal cells: Five-years of follow-up Journal of Crohn s and Colitis ·Н А Фадеева, O. V. Knyazev, A Kagramanova, A. Babayan, A Lishchinskaya, И Н Ручкина, A. G. Konoplyannikov, А И Парфенов	2018	4
9	Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice Terapevticheskii arkhiv ·O. V. Knyazev, A Kagramanova, A Lishchinskaya, Н. Г. Самсонова, Orlova Nv, В А Рогозина, А И Парфенов	2018	3
10	Current principles in the screening, diagnosis, and therapy of colorectal cancer Terapevticheskii arkhiv ·Igor Khatkov, A Kagramanova, N B Zakharzhevskaya, E A Babikova, Edward V. Generozov, П. Л. Щербаков, А И Парфенов	2016	3
11	Loss of response and frequency of adverse events in patients with ulcerative colitis and Crohn’s disease when switching from the original infliximab to its biosimilars Terapevticheskii arkhiv ·O. V. Knyazev, Mariya Zvyaglova, A Kagramanova, I. А. Li, Sabel'nikova Ea, A Lishchinskaya, D Kulakov, А И Парфенов	2021	3
12	P526. Sampling not at trough: adalimumab serum drug and antibody levels remain relatively stable in between injections Journal of Crohn s and Colitis ·O. V. Knyazev, A Kagramanova, С Г Хомерики, A. Konoplyannikov, К. К. Носкова, Н А Фадеева, А И Парфенов	2016	2
13	Evaluation of efficacy and comparative frequency of adverse events in patients with ulcerative colitis receiving the original infliximab and its biosimilar. One year of observation SHILAP Revista de lepidopterología ·O. V. Knyazev, T.V Shkurko, A Kagramanova, A Lishchinskaya, Mariya Zvyaglova, I A Korneeva, Anait Babayan, А И Парфенов	2019	2
14	Efficacy and safety of tofacitinib for moderate and severe ulcerative colitis in real clinical practice: an open observational prospective study Фарматека ·O. V. Knyazev, Т. В. Шкурко, A Kagramanova, A Lishchinskaya, D.S. Bordin Bordin, А И Парфенов	2020	2
15	Efficacy of adalimumab for Crohn’s disease in real clinical practice Terapevticheskii arkhiv ·O. V. Knyazev, A Kagramanova, И Н Ручкина, Н А Фадеева, A Lishchinskaya, О Н Болдырева, E.Yu. Zhulina Zhulina, П. Л. Щербаков, N. V. Orlova, М В Кирова, А И Парфенов	2017	2
16	P179 Changes in the haemostatic system in patients with ulcerative colitis depending on the degree of activity of the disease Journal of Crohn s and Colitis ·O. V. Knyazev, A Kagramanova, A Lishchinskaya, Г. А. Дудина, В. В. Субботин, К. К. Носкова, А И Парфенов	2019	2
17	The effectiveness of mesalazine therapy of ulcerative colitis of moderate severity in real clinical practice SHILAP Revista de lepidopterología ·O. V. Knyazev, A Kagramanova, A Lishchinskaya, А И Парфенов	2019	2
18	Efficacy and safety of ustekinumab therapy in patients with Crohn’s disease. Real clinical practice Meditsinskiy sovet = Medical Council ·O. V. Knyazev, A Kagramanova, A.A. Lischinskaya, I. А. Li, Sabel'nikova Ea, A N Demchenko, B. А. Nanaeva, E.Yu. Zhulina Zhulina, N. V. Kamzarakova, Margarita V. Chebotareva, Н А Фадеева, Karina Nikolskaya	2022	1
19	CROHN'S DISEASE. TO THE 90th ANNIVERSARY OF THE DESCRIPTION Problems of Social Hygiene Public Health and History of Medicine ·Т. В. Шкурко, A Kagramanova, O. V. Knyazev	2022	1
20	THE RESULTS OF THE USE OF 5-AMINOSALICYLIC ACID AS AN ANTI-RELAPSE AND MAINTENANCE THERAPY ULCERATIVE COLITIS MODERATE SEVERITY IN CLINICAL PRACTICE Meditsinskiy sovet = Medical Council ·O. V. Knyazev, A Kagramanova	2017	1

About A Kagramanova

A Kagramanova is a scholar working on Genetics, Epidemiology, Surgery, Immunology and Oncology, having authored 46 papers that have together received 108 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (35 papers), Microscopic Colitis (22 papers), Autoimmune and Inflammatory Disorders (6 papers), Pharmacological Effects of Natural Compounds (4 papers), Eosinophilic Esophagitis (4 papers), Anorectal Disease Treatments and Outcomes (3 papers), Hidradenitis Suppurativa and Treatments (3 papers) and Biomarkers in Disease Mechanisms (3 papers). The work is most often cited by research in Genetics (73 citations), Epidemiology (63 citations), Immunology (28 citations), Pharmacology (11 citations) and Genetics (13 citations). A Kagramanova has collaborated with scholars based in Russia, South Korea and United States. Frequent co-authors include O. V. Knyazev, А И Парфенов, А. V. Veselov, Orlova Nv, И. Г. Бакулин, Л. С. Круглова, E. А. Belousova, П. Л. Щербаков, Marina Koroleva and А. N. Lvov. Their work appears in journals such as Journal of Crohn s and Colitis, The American Journal of Gastroenterology, Terapevticheskii arkhiv, Inflammatory Bowel Diseases and Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

A Kagramanova

Impact in

Papers in i

In The Last Decade

A Kagramanova

Peers

Countries citing papers authored by A Kagramanova

Fields of papers citing papers by A Kagramanova

All Works

About A Kagramanova

Explore authors with similar magnitude of impact

Papers in